158
Participants
Start Date
May 31, 2018
Primary Completion Date
December 9, 2019
Study Completion Date
December 9, 2019
TEV-50717
6-, 9-, 12-, 15-, and 18 mg oral tablets
Placebo
Placebo matched to TEV-50717 tablets will be taken BID.
Teva Investigational Site 060-0901, Budapest
Teva Investigational Site 060-1403, La Plata
Teva Investigational Site 060-1802, Liverpool
Teva Investigational Site 060-1801, Parkville
Teva Investigational Site 060-1904, Seoul
Teva Investigational Site 060-2007, Kiev
Teva Investigational Site 060-2005, Kyiv
Teva Investigational Site 060-1404, Mendoza
Teva Investigational Site 060-1902, Seoul
Teva Investigational Site 060-0902, Szeged
Teva Investigational Site 060-0154, New York
Teva Investigational Site 060-2006, Vinnytsia
Teva Investigational Site 060-0168, Atlanta
Teva Investigational Site 060-1105, Krakow
Teva Investigational Site 060-0160, Gainesville
Teva Investigational Site 060-0151, Orlando
Teva Investigational Site 060-0153, Orlando
Teva Investigational Site 060-1603, León
Teva Investigational Site 060-0157, Memphis
Teva Investigational Site 060-0158, Louisville
Teva Investigational Site 060-0152, Indianapolis
Teva Investigational Site 060-0165, Ann Arbor
Teva Investigational Site 060-2003, Dnipropetrovsk
Teva Investigational Site 060-0155, Chicago
Teva Investigational Site 060-0164, Chicago
Teva Investigational Site 060-2001, Kharkiv
Teva Investigational Site 060-2002, Kharkiv
Teva Investigational Site 060-0170, Bridgeton
Teva Investigational Site 060-1602, Monterrey
Teva Investigational Site 060-1604, Monterrey
Teva Investigational Site 060-0163, Fort Worth
Teva Investigational Site 060-1601, Culiacán
Teva Investigational Site 060-1003, Naples
Teva Investigational Site 060-1001, Catania
Teva Investigational Site 060-1504, Pereira
Teva Investigational Site 060-1501, Medellín
Teva Investigational Site 060-0166, Gulf Breeze
Teva Investigational Site 060-0161, Miami
Teva Investigational Site 060-0167, Rockville
Teva Investigational Site 060-0169, Charleston
Teva Investigational Site 060-0156, Nashville
Teva Investigational Site 060-0162, Everett
Teva Investigational Site 060-1407, Buenos Aires
Teva Investigational Site 060-1401, Buenos Aires
Teva Investigational Site 060-1402, Buenos Aires
Teva Investigational Site 060-1503, Bello
Teva Investigational Site 060-1506, Medellín
Teva Investigational Site 060-1005, Cagliari
Teva Investigational Site 060-1004, Rome
Teva Investigational Site 060-1104, Gdansk
Teva Investigational Site 060-1101, Katowice
Teva Investigational Site 060-1102, Poznan
Teva Investigational Site 060-1106, Torun
Teva Investigational Site 060-1103, Warsaw
Teva Investigational Site 060-1901, Seoul
Teva Investigational Site 060-1903, Seoul
Collaborators (1)
Nuvelution TS Pharma, Inc.
INDUSTRY
Teva Branded Pharmaceutical Products R&D, Inc.
INDUSTRY